MS Clinical Psychopharmacology
Psychologists have always been leaders in the provision of quality mental and behavioral healthcare to their patients. As part of their commitment to continuity of care, psychologists are increasingly working collaboratively with physicians and other medical providers surrounding the psychopharmacological treatment of the individuals they serve. In the next step in this process, psychologists have achieved prescriptive authority in several states and other settings. Preliminary evidence finds them to be safe and effective prescribers. It has even been suggested that psychologists have an ethical obligation to continue their training in psychopharmacology and the impact of biological factors on emotional disorders (Barnett & Neel, 2000).
The M.S. Program in Clinical Psychopharmacology was developed as a postdoctoral program for licensed psychologists in psychopharmacology to prepare for prescriptive authority. In fact, graduates of the program are currently prescribing in all settings where psychologists have achieved this authority, including Guam, Louisiana, New Mexico, Illinois, Iowa, Idaho, the Indian Health Service, the Public Health Service, and various branches of the United States military. Whether psychologists choose to become better collaborators with other prescribing professionals or independent prescribers, the M.S. Program in Clinical Psychopharmacology offers the additional education and training necessary to achieve that goal. The program is dedicated to training psychologists in clinical psychopharmacology in a way that respects and builds on psychologists’ traditional competencies in assessment and diagnosis, psychosocial intervention, and empirically-based methods.
The M.S. in Clinical Psychopharmacology (MSCP) program has continuously been an APA-designated program since 2010, the first MSCP program to achieve this status. APA designation means the program meets standards for preparing psychologists as prescribers set forth in APA’s Designation Criteria for Education and Training Programs in Psychopharmacology for Prescriptive Authority based on the APA Model Education and Training Program in Psychopharmacology for Prescriptive Authority.
The MS Program in Clinical Psychopharmacology is housed in the School of Psychology and Counseling of Fairleigh Dickinson University. The School of Psychology and Counseling has a long tradition of graduate-level training in psychology that emphasizes the applied, conceptual, and scientific components of professional psychology. Among other programs, the School also offers an APA-accredited PhD scientist-practitioner program in clinical psychology, as well as a PsyD program in school psychology.
The MS Program in Clinical Psychopharmacology is dedicated to enhancing licensed psychologists’ ability to interact and collaborate with other health professionals in the management of patients with mental and behavioral disorders. The program is also committed to training psychologists to the level of competence appropriate for independent prescriptive authority. The didactic program uses a combination of distance and online teaching methods, emphasizing applied learning via case formulation, to achieve these goals. Participants are also eligible to participate in a supervised clinical experience, which prepares the participant for independent practice. This clinical experience uses a mentoring model geared for mastery of core clinical competencies. The format of the program allows for a rigorous and demanding learning environment, as is appropriate given the goals of the program, while providing the flexibility needed for busy professionals to complete the training. The program adopts a learner-centered approach that builds on the tradition and excellence of the scientist-practitioner training model, enhancing scientific and professional knowledge by delivering high-quality education through the latest technology and peer-interaction techniques.
The program provides a strong knowledge base in psychopharmacology and medical conditions relevant to the treatment of mental disorders. This knowledge can immediately facilitate your collaborative practice skills. The program requirements meet or exceed requirements outlined in the APA Model Education and Training Program in Psychopharmacology for Prescriptive Authority. In addition to the elective supervised clinical experience, the program includes virtual clinical application through case studies incorporated into each of the ten didactic courses.
The M.S. Program in Clinical Psychopharmacology is a primarily distance-based program that was developed by the Fairleigh Dickinson University School of Psychology in collaboration with Compass Knowledge Group (now Pearson Embanet), a national leader in distance-based educational programs. This unique approach to student-centered distance learning provides the opportunity to obtain and apply knowledge that is directly relevant to the professional development and learning objectives of the student.
Multiple teaching modalities are employed to create a program combining rigor and flexibility. These modalities include:
- videotaped lectures
- use of online resources
- online chats and discussion boards
- traditional readings
- case formulation and presentation
The didactic portion of the program consists of 10 courses, each specifically designed and developed for doctorally-prepared licensed psychologists. A sequence of core courses provides a basic science foundation and clinical knowledge in psychopharmacology. A professional issues course addresses legal and ethical considerations and related standards of care topics. The didactic curriculum concludes with a series of treatment courses addressing specific categories of mental disorders and related psychopharmacological issues. After completion of the 10-course sequence, participants are eligible to sit for a comprehensive, in-house, Qualifying Examination. Upon passing the Qualifying Examination, the psychologist receives the postdoctoral Master of Science in Clinical Psychopharmacology (MSCP), which indicates completion of the didactic experience the APA has developed in preparation for prescriptive authority. Graduates of the master’s program are eligible to participate in an elective supervised clinical experience to complete APA’s recommended model for independent prescribing practice. The Psychopharmacology Examination for Psychologists (PEP), which is maintained by the Association of State and Provincial Psychology Boards (ASPPB) specifically as a credentialing examination for psychologists with advanced training in clinical psychopharmacology, is also required for prescribing practice in most jurisdictions that have passed prescriptive authority legislation.
From the very beginning, both clinical and didactic training are stressed. For each course, the student is assigned a Course Instructor, typically a nationally recognized expert and researcher in the course content. Similarly, videotaped lectures feature speakers selected for their expertise in the knowledge domain. Most instructors combine case formulation with didactic instruction in weekly chats to help solidify the information.
There is a national examination available in psychopharmacology that represents the doorway to licensure to prescribe, called the Psychopharmacology Examination for Psychologists (PEP). That examination evaluates success in relation to 10 learning objectives:
- Integrating clinical psychopharmacology with the practice of psychology.
- Understanding the implications of neuroscience for the action of pharmacological agents.
- Understanding the development of nervous system pathology.
- Learning elements of physiology and pathophysiology relevant to prescribing.
- Developing a biopsychosocial understanding of pharmacologic assessment and monitoring.
- Enhancing skills in differential diagnosis as they relate to psychopharmacological practice.
- Developing a knowledge of pharmacology.
- Developing an extensive understanding of clinical psychopharmacology.
- Understanding research issues in psychopharmacological practice.
- Understanding professional, legal, and ethical issues specific to involvement in psychopharmacology
The M.S. Program in Clinical Psychopharmacology was developed for individuals licensed at the doctoral level as psychologists. If you are an unlicensed psychologist or a licensed health care provider in another field or at the master’s level, please contact the Program Director, Dr. Derek Phillips, at firstname.lastname@example.org to discuss your options. Psychologists and other healthcare professionals desiring to participate in individual courses should contact us rather than completing the application.
To begin courses in the fall term (September), please submit your application through the online graduate admissions portal by July 15. To begin courses in the spring term (January), please submit your application by November 15. We recommend beginning courses in September.
- A completed online graduate application
- Official transcripts from all colleges/universities/college-level coursework attended
- Current copy of psychologist licensure
- Current curriculum vitae (Please indicate if you are a member of a state psychological association and if so, which one. Also indicate if you are a member of APA Division 18 or 55.)
- Proof of respecialization as a clinician, if applicable
- Letters of recommendation are not required
Minimum Computer Requirements
- Desktop, Laptop or Portable with Pentium II 300 MHz processor, 64 MB RAM, 2 GB Free Hard Drive Space, Broadband Internet Access.
- Windows XP or higher, MS Office 97 or higher, Email Address, Internet Browser, Java Plugin, Windows Media Player, Real Media Player, Adobe Acrobat Reader.
Students are required to have a computer meeting or surpassing the minimum requirements. Substitutions are possible so long as they are equivalent in their ability to work with files.
The Master of Science in clinical psychopharmacology (MSCP) program consists of a series of 10 courses specifically designed and developed for psychologists seeking to expand their knowledge of psychopharmacology. A sequence of core courses provides the basic science foundation and knowledge base in pathophysiology, neuroscience, and pharmacology for clinical applications. A professional issues course addresses the legal and ethical considerations and related standard of care topics. The didactic program concludes with a series of treatment courses addressing specific categories of mental disorders and the related psychopharmacological issues. These courses provide psychologists with important knowledge of the treatment of mental disorders with medication. A clinical practicum elective is available for those practitioners who desire to practice the management of psychopharmacotherapy in a supervised clinical experience.
In addition to required readings and videotapes lectures, students participate in online discussions and weekly chats. These chats represent the only weekly requirement that is scheduled; all other activities occur at the convenience of the participant.
The didactic portion of the program is divided into five, 15-week semesters. Two courses are completed each semester. Courses run sequentially to allow participants to focus on one topic at a time.
These courses present an integrated approach to the study of primary body systems (respiratory, cardiovascular, renal, hematologic/immunologic, gastrointestinal, endocrine, reproductive, musculoskeletal, and dermatologic) that correlates fundamental knowledge of the anatomy, physiology, and pathophysiology of a specific body system with the clinical applications (health assessment, physical examination, laboratory assessment) pertaining to that system. Exploration of clinical medicine concepts will utilize a problem-solving approach. The goals of these two courses are to enhance the student’s recognition of signs and symptoms of medical conditions requiring collaboration with and referral to other health professionals and to provide knowledge about the psychological, biological, and medical correlates of disease. Medical sequelae of psychotropic agents and familiarity with standard medical treatment of common disease states are addressed. Each course is worth 3 academic credits.
Course 3: PSYC7920 Neuroscience (7.5 weeks)
This course focuses on the anatomy and physiology of the nervous system, beginning at the cellular level. Knowledge of principles of neurochemistry, neuroendocrinology, and neuropathology will serve as a foundation for the understanding of neurotransmitter systems and their role in the etiology and treatment of mental disorders. 3 academic credits.
Course 4: PSYC7925 Neuropharmacology (7.5 weeks)
This course introduces the knowledge base pertaining to pharmacology and psychopharmacology. It includes continued study of neurotransmitter systems and other factors in the psychopharmacological treatment of mental disorders, as well as an introduction to classes of psychotropic medications. 3 academic credits.
Course 5: PSYC7930 Clinical Pharmacology (7.5 weeks)
This course presents major classes of drugs (excluding psychotropics) and their uses in clinical settings. It includes an examination of the social, cultural, and behavioral aspects of prescribing medications. 3 academic credits.
Course 6: PSYC7935 Professional Issues & Practice Management (7.5 weeks)
This course reviews issues in prescribing from the perspective of a professional healthcare provider. Legal and ethical issues, as well as standards of care ranging from informed consent to documentation, are addressed. Interprofessional relationships and aspects of collaborative practice, as well as practice enhancement strategies such as computer-based aids, will provide learners with a solid foundation for the continued integration of psychopharmacology into their practices. 3 academic credits.
Courses 7-10: Treatment Issues in Psychopharmacology (7.5 weeks each)
- PSYC7940 Affective Disorders
- PSYC7945 Psychotic Disorders
- PSYC7950 Anxiety Disorders
- PSYC7955 Other Disorders
This treatment-focused series of courses provides students with access to virtual clinical experiences through didactic information and case studies addressing specific categories of mental disorders. Each case addresses the following: diagnosis/differential diagnosis; etiology/biological basis of disorder; psychopharmacological treatment options, including mechanism of action, side effects, adverse reactions, polypharmacy, drug interaction, and patient education. The integration of treatment strategies, as well as the empirical basis for treatments, is presented. Disorders covered will include mood disorders, psychotic disorders, anxiety disorders, neurocognitive disorders, substance use disorders, chronic pain, Posttraumatic Stress Disorder, and Attention-Deficit/Hyperactivity Disorder, and others. Each course is worth 3 academic credits.
The Qualifying Exam
To verify mastery of the material, there is an online Qualifying Exam offered upon completion of coursework. The Qualifying Exam is offered twice yearly and is free. An optional, face-to-face preparatory course is also offered to prepare for this exam, called the PEP Prep. Upon passage of the Qualifying Exam, the student receives the postdoctoral Master of Science degree in clinical psychopharmacology (MSCP).
Clinical Laboratory Course/PEP Preparatory Course
An optional training experience intended for students who have recently completed the program is offered yearly. Called the Clinical Lab/PEP Prep, this typically takes place in Chicago in August, but also may be virtual if need be. The Clinical Lab portion consists of five days of clinical training. Topics addressed include physical exam, medical history taking, and interpretation of clinical labs. Completion of the Clinical Lab or a similar experience that the student develops in their local community is a requirement of the FDU Practicum. The Clinical Lab is followed by the PEP Prep. Despite its name, the intention is to prepare the student either for the Psychopharmacology Examination for Psychologists or for the in-house Qualifying Exam. Students can sign up for the Clinical Lab, PEP Prep, or both. This experience is not eligible for academic credit.
PSYC7960 Clinical Psychopharm Practicum Elective
Practitioners who successfully complete the 10 didactic courses will be eligible to enroll in the Clinical Practicum. This is part of the supervised clinical experience described in the APA Model Education and Training Program in Psychopharmacology for Prescriptive Authority. Each participant in the practicum will identify, arrange with, and recommend a clinical supervisor preceptor (MD or DO) to be approved by Fairleigh Dickinson University. This experience may be arranged within the student’s local community. The Program Director will assist in the identification of an appropriate preceptor if needed, but cannot guarantee a placement.
A lengthy set of guidelines have been developed for the conduct of the practicum; however, states with their own guidelines for completion of the practicum/supervised clinical experienced take precedence over FDU’s guidelines. Passage of the Qualifying Exam is not required prior to beginning the Practicum.
MS in Clinical Psychopharmacology Program Faculty/Staff
Derek C. Phillips, PsyD, MSCP
Dr. Derek Phillips is a licensed clinical psychologist in the states of Illinois and Florida and a clinical neuropsychologist in the Department of Neurology at Sarah Bush Lincoln Health Center in east central Illinois, where he is also currently completing medical rotations for his prescribing psychology residency to become a licensed prescribing psychologist in Illinois. Dr. Phillips serves as a Health Service Psychologist in the National Health Service Corps Loan Repayment Program through the U.S. Department of Health and Human Services. As of July 2020, he is Director of the M.S. program in clinical psychopharmacology (MSCP) at Fairleigh Dickinson University in Teaneck, NJ, as well as adjunct professor in FDU’s clinical psychology PhD program. Previous academic appointments included adjunct professorships at Lake Land College and in the M.A. in clinical psychology program at Eastern Illinois University. Dr. Phillips is a 2019 graduate of FDU’s MSCP program. To help fund this endeavor, he was awarded the Walter Katkovsky Scholarship for Psychopharmacology Training in 2017 by the American Psychological Foundation (APF). Dr. Phillips obtained his Bachelor of Science degree in psychology (summa cum laude) from Olivet Nazarene University in 2009, as well as his Master of Arts degree in counseling psychology and Doctor of Psychology in clinical psychology (clinical neuropsychology concentration) from the APA-Accredited Adler University – Chicago campus in 2012 and 2015, respectively.
Regarding current service to psychology, Dr. Phillips is a member of the APA Board of Convention Affairs, Secretary of Division 42 (Independent Practice), Treasurer of Division 44 (Psychology of Sexual Orientation and Gender Diversity), a member-at-large of the Illinois Association of Prescribing Psychologists Board of Directors, and Chair of the Sexual Orientation and Gender Diversity Section of the Illinois Psychological Association. Additionally, he has been elected the first-ever ECP President of APA Division 55 (American Society for the Advancement of Pharmacotherapy) and will serve as President in 2021. He also serves on the Editorial Board for the journal Experimental and Clinical Psychopharmacology. Previous service includes: member of the APA Council of Representatives from Division 55, member of the APA Practice Organization’s Committee for the Advancement of Professional Practice (CAPP), Social Responsibility Section Associate Chair and Graduate Student Section Chair (IPAGS) of the Illinois Psychological Association, ECP Chair of the Florida Psychological Association, member of the Division 40 (Clinical Neuropsychology) Early Career Neuropsychologist Committee, and Co-Chair of the Division 42 Student/ECP Committee.
Michael A. Ansonoff, PhD
Dr. Ansonoff received his PhD from the Sue Golding Graduate program at Albert Einstein Medical School of Yeshiva University (Neuroscience Program) following training in the laboratory of Dr. Anne Etgen on cellular and behavioral mechanisms by which ovarian steroids regulate brain function. His research involved investigating the regulatory mechanisms by which ovarian steroids desensitize adrenergic receptors in the female rodent. He then completed a 5-year post-doctoral fellowship at the University of Medicine and Dentistry of New Jersey studying the behavioral and pharmacological consequences of opioid receptor gene ablation in mice. Presently, he is still at the University of Medicine and Dentistry of New Jersey, however, his research interests have shifted towards examining the consequences of the knockout of the nociceptin receptor and its endogenous ligand on food consumption and obesity. In addition, he has developed a keen interest in science education leading him to complete an MA in education at Fairleigh Dickinson University.
Anne R. Farrar-Anton, PhD, MSCP
Dr. Anne Farrar-Anton is a licensed psychologist in New Jersey and New York. Dr. Farrar-Anton earned her master’s in counseling and her doctorate degree in counseling psychology from Seton Hall University in South Orange, NJ. Dr. Farrar-Anton completed a two-year postdoctoral fellowship in pediatric neuropsychology at the Institute for Child Development at Hackensack University Medical Center. Dr. Farrar-Anton completed a postdoctoral Master of Science in clinical psychopharmacology (MSCP, 2009) from Fairleigh Dickinson University, along with the Certificate Program in Integrated Primary Care (2011) in order to better understand psychotropic medications as well as how to collaborate/integrate psychology within a medical setting. Dr. Farrar-Anton is able to utilize her knowledge on psychotropic medications to better understand her patient’s symptoms and be able to collaborate with the physicians prescribing these various medications.
Dr. Farrar-Anton previously served as Director of the postdoctoral MSCP program at Fairleigh Dickinson University from 2015-2020. She now serves as an adjunct professor for the School of Psychology and Counseling and the School of Education, as well as a testing/therapy supervisor at the Center for Psychological Services. Dr. Farrar-Anton teaches the Professional Development and Ethics course (PSYC 7935) for the MSCP program.
She has been with Hackensack University Medical Center for the past 18 years in various capacities and is currently on Medical Staff within the Department of Psychiatry and Pediatrics. She began working at the Institute for Child Development and was there for 5.5 years prior to transitioning to the Children’s Cancer Institute where she has worked for the past 18 years; she has been working with the patients and their families who have been diagnosed with various types of cancer, blood disorders, or those requiring a bone marrow transplant. She currently serves as the Supervisor of the Psychological and Educational services; she conducts comprehensive neuropsychological evaluations, psychotherapy and crisis counseling with children and families, supervises and trains doctoral students, and has an active research agenda. Her primary goal is to assist the children and families suffering from various life-threatening medical illnesses to find adaptive ways to cope with the stressors that are presented to them and utilizes a biopsychosocial orientation. The focus can be anywhere on the spectrum from adjusting to diagnosis, survivorship issues and late effects of treatment, palliation, to end-of-life issues.
Dr. Farrar-Anton established a small private practice in 2010 in Bergen County and provides both psychological and neuropsychological services with weekend hours. She has been involved in numerous leadership positions at the county, state, and national level, as well as is involved with national psychological and neuropsychological organizations. In July 2015, Dr. Farrar-Anton was appointed by the Governor to serve on the New Jersey Board of Psychological Examiners, which is the state licensing board. She is currently serving as Secretary of the New Jersey Neuropsychological Society. In addition, Dr. Farrar-Anton has been involved in the New Jersey Psychological Association in numerous capacities including previously completing serving several terms as a Member of the Executive Board. She is also an author of several journal publications and a book chapter. In her free time, she enjoys spending time with her therapy and agility dog, learning ballroom dancing, and reading.
Rachel Heaney, MSN, APN
Rachel graduated from Ithaca College in 1991 with a Bachelor of Arts in sociology of health and medicine. She then went to Marymount University and graduated with a Bachelor of Science in Nursing in 1993. She worked as a staff nurse on the Pediatric Oncology unit at Georgetown University Medical Center for 5 years. She then went to the University of Pennsylvania for her Master’s in Nursing and became a pediatric nurse practitioner and graduated in the summer of 1999. She has been employed at Hackensack University Medical Center as a pediatric advanced practice nurse since October of 1999. Rachel has worked in both the inpatient setting and the outpatient clinic. She precepts many advanced practice nursing students from many programs and colleges. She enjoys educating new families and patients and holds a special place in her heart for the adolescent population.
Bret A. Moore, PsyD, ABPP
Bret A. Moore is a board certified clinical psychologist in San Antonio, Texas, Prescribing Psychologist in New Mexico, and Adjunct Associate Professor of Psychiatry at the University of Texas Health Science Center at San Antonio. He is the author or editor of ten books including “Pharmacotherapy for Psychologists: Prescribing and Collaborative Roles,” “Handbook of Clinical Psychopharmacology for Psychologists,” and “Anxiety Disorders: A
Guide for Integrating Psychopharmacology and Psychotherapy,” which he co-edited with Stephen Stahl. He is also the series editor of “Psychopharmacology and Psychotherapy in Clinical Practice” for Routledge/Taylor & Francis Press.
Dr. Moore is a former active-duty Army psychologist and two-tour veteran of Iraq. He is a recipient of the Arthur W. Melton Award for Early Career Achievement in Military Psychology from Division 19 of the American Psychological Association and the Early Career Achievement Award from Division 18, and is a Fellow of the American Psychological Association. His views and opinions on clinical and military psychology have been quoted in USA Today, the New York Times, and the Boston Globe, and on NPR, the BBC, CNN, CBS News, Fox News, and the CBC.
Merrill A. Norton, PharmD, DPh, ICCDP-D
Dr. Norton is a Clinical Associate Professor at the University of Georgia College of Pharmacy with his specialty areas to include psychopharmacology and addiction pharmacy. In addition to being MSCP faculty at FDU, he has also been a faculty member at the California School of Professional Psychology at Alliant International University, the University of Georgia School of Continuing Education, and Berry College in the areas of psychopharmacology and addiction pharmacy. His area of specialty in addiction pharmacy is the management of chronic pain in the addicted patient.
Dr. Merrill Norton was honored by the Georgia Addiction Counselors Association in receiving the prestigious Distinguished Service Award for 2015. The award is bestowed on individuals for recognition of their long-term support and commitment to the treatment and welfare of those affected by alcohol and drug addiction in Georgia and nationally. Dr. Norton’s efforts of educating thousands of behavioral health practitioners nationally to the disease states of substance use disorders and his dedication to the early prevention and intervention of addictive disease in Georgia’s families makes him a person uniquely qualified for this award. In addition, Dr. Norton was the 2009 recipient of the Georgia School of Addiction Studies (GSAS) Excellence in Addiction Treatment Individual Achievement Award “for his unselfish dedication to the treatment of addicted families, not only in the state of Georgia, but nationally.” Dr. Norton was recognized by the GSAS Board of Directors for the ongoing development of undergraduate and graduate curriculum and drug research in the area of addiction pharmacy.
His book, “The Pharmacology of Psychoactive Chemical Use, Abuse, and Dependence;” and his DVD series, “The Hijacking of the Brain” have been used to train thousands of mental health professionals nationally. They have become the standards of teaching excellence in the addiction treatment profession. He also released another book, “The Pharmacology of Substance Use Disorders,” in 2016.
Lynette Pujol, PhD, MSCP
Lynette A. Pujol is a clinical psychologist and full-time psychopharmacology prescriber. She completed a two-year clinical and research fellowship in behavioral medicine at the Johns Hopkins School of Medicine. She was subsequently employed in an anesthesiology-based pain management practice at a large medical school where she performed research and provided clinical services. She has assisted in the design of a pain education website designed to educate physicians, nurses, pharmacists, and psychologists. She is the primary author of the trade book “10 Hidden Barriers to Weight Loss and Exercise.” Dr. Pujol has been the Primary Investigator or Co-Investigator on studies involving spinal cord stimulation, functional restoration, diabetes prevention, sleep, and suicide-specific treatments. She currently prescribes psychotropic drugs through a regional virtual behavioral health hub. She writes and publishes on topics related to evidence-based medicine delivered through tele-behavioral health, the application of technology, and psychopharmacology.
Resources for Psychologists
Existing Prescriptive Authority Laws
The following are links to enacted legislation granting psychologists prescriptive authority.
Statute: Guam Public Law 24-329, Article 12, Section 121205
Statute: Indiana Code 25-33
New Mexico (2002)
Statute: Chapter 154B: Psychology
Statute: Title 54 Chapter 23
Opinions on Collaboration
A number of state psychology licensing boards have generated statements verifying that discussions of medication are within the scope of practice of psychology. An opinion of this type from your state licensing board offers a level of protection for psychologists who consider it in the best interests of their patients to consult with patients and/or their physicians on medications. A current list of such statements is available here. If your state board has generated this type of statement and it is not included in this document, we would appreciate your bringing it to the attention of the Program Director, Dr. Derek Phillips, at email@example.com. If your state board has not generated this type of statement, you may want to share this document with them and request that they do so.
- APA Model Education and Training Program in Psychopharmacology for Prescriptive Authority
- APA Designation Criteria for Education and Training Programs in Psychopharmacology for Prescriptive Authority
- APA Model Legislation for Prescriptive Authority
- APA Practice Guidelines Regarding Psychologists’ Involvement in Pharmacological Issues
- Psychopharmacology Examination for Psychologists (PEP)
- APA Division 55 (American Society for the Advancement of Pharmacotherapy)
- Epocrates Drug Reference
- Prescriber’s Digital Reference App